Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis

Goodin, Douglas; Biermann, Louis; Bohlega, Saeed; Boiko, Alexey; Chofflon, Michel; Gebeily, Souheil; Gouider, Riadh; Havrdova, Eva; Jakab, Gabor; Karabudak, RANA; Karussis, Dimitrios; Miller, Ariel; Pakdaman, Hossein; Selmaj, Krzysztof; Sharief, Mohammad

doi:10.1185/03007x233007

Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis

Goodin D. S., Biermann L. D., Bohlega S., Boiko A., Chofflon M., Gebeily S., ...Daha Fazla

CURRENT MEDICAL RESEARCH AND OPINION, cilt.23, sa.11, ss.2823-2832, 2007 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 23 Sayı: 11
Basım Tarihi: 2007
Doi Numarası: 10.1185/03007x233007
Dergi Adı: CURRENT MEDICAL RESEARCH AND OPINION
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.2823-2832
Hacettepe Üniversitesi Adresli: Evet

Özet

Background: As results from an increasing number of clinical trials with disease-modifying drugs (DMDs) in multiple sclerosis (MS) become available, the challenge for the treating is how to decide on the appropriate therapy for an individual patient.